Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta‐analysis

Hepatitis B surface antigen (HBsAg) seroclearance is regarded as the ideal endpoint for antiviral treatment. However, reports on the durability of and outcomes after HBsAg seroclearance are few, which has become a focus in clinical practice. This meta‐analysis was performed to evaluate the durabilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Aixin, Wang, Xiaoxiao, Lu, Junfeng, Jin, Yi, Ma, Lina, Hu, Zhongjie, Zheng, Yanhong, Shen, Chengli, Chen, Xinyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986681/
https://www.ncbi.nlm.nih.gov/pubmed/33455067
http://dx.doi.org/10.1111/jvh.13471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986681/
https://www.ncbi.nlm.nih.gov/pubmed/33455067
http://dx.doi.org/10.1111/jvh.13471

Ejemplares similares